Publications
Husain M, Donsmark M, Bain SC. Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply. N Engl J Med. 2019 Nov 21;381(21):2076-2077. doi: 10.1056/NEJMc1913157. No abstract available. PMID: 31747740
Keay N, Bracken RM. Managing type 1 diabetes in the active population. Br J Sports Med. 2019 Nov 15. pii: bjsports-2019-101368. doi: 10.1136/bjsports-2019-101368. [Epub ahead of print] No abstract available. PMID: 31732652
Bain S, Feher M, Fisher M, Hex N, Lee KCS, Mahon J, Russell-Jones D, Schou H, Wilmot EG, Baxter M. A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes. Diabet Med. 2019 Nov 15. doi: 10.1111/dme.14180. [Epub ahead of print]. PMID: 31729775
Verma S, Bain SC, Buse JB, Idorn T, Rasmussen S, Ørsted DD, Nauck MA. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2019 Nov 13. doi: 10.1001/jamacardio.2019.3080. [Epub ahead of print]. PMID: 31721979
Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD. An update to: Pharmacological treatment for type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabet Med 2019; 36: 1063-1071. Diabet Med. 2019 Nov 5. doi: 10.1111/dme.14172. [Epub ahead of print] No abstract available. PMID: 31691349
Douglas TD, Stephens JW, Barry J, Lee MD, Wilkinson LL. The influence of attachment orientation on weight loss, eating behaviour and other health outcomes among patients undergoing bariatric surgery: A systematic scoping review. Appetite. 2019 Nov 2:104504. doi: 10.1016/j.appet.2019.104504. [Epub ahead of print] Review. PMID: 31689448
Yang JHM, Khatri L, Mickunas M, Williams E, Tatovic D, Alhadj Ali M, Young P, Moyle P, Sahni V, Wang R, Kaur R, Tannahill GM, Beaton AR, Gerlag DM, Savage COS, Napolitano Rosen A, Waldron-Lynch F, Dayan CM, Tree TIM. Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry. Front Immunol. 2019 Oct 31;10:2547. doi: 10.3389/fimmu.2019.02547. eCollection 2019. PMID: 31749806
Price DB, Voorham J, Brusselle G, Clemens A, Kostikas K, Stephens JW, Park HY, Roche N, Fogel R. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. NPJ Prim Care Respir Med. 2019 Oct 28;29(1):38. doi: 10.1038/s41533-019-0150-x. PMID: 31659161
Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019 Oct 23:107840. doi: 10.1016/j.diabres.2019.107840. [Epub ahead of print] Review. PMID: 31733978
Landgraf W, Owens DR, Frier BM, Zhang M, Bolli GB. Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL. Diabetes Obes Metab. 2019 Oct 13. doi: 10.1111/dom.13897. [Epub ahead of print]. PMID: 31608548